Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types.

Chandani Limbad1, Ryosuke Doi1, Julia McGirr1

  • 1Buck Institute for Research on Aging, Novato, CA, USA.

Iscience
|February 24, 2022
PubMed
Summary

Researchers identified 25-hydroxycholesterol (25HC) as a novel senolytic drug. This compound effectively clears senescent cells, offering a potential therapeutic strategy for age-related diseases driven by cellular senescence.